Immune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas

被引:0
|
作者
Boileve, A. [1 ]
Carlo, M. [2 ]
Barthelemy, P. [3 ]
Oudard, S. [4 ]
Borchiellini, D. [5 ]
Voss, M. [2 ]
George, S. [6 ]
Chevreau, C. [7 ]
Landman-Parker, J. [8 ]
Tabone, M-D. [8 ]
Chism, D. [9 ]
Amin, A. [10 ]
Bilen, M. A. [11 ]
Bosse, D. [12 ,13 ]
Choueiri, T. K. [12 ,13 ]
Tannir, N. [14 ]
Malouf, G. [1 ]
机构
[1] Univ Hosp Pitie Salpetriere, Dept Med Oncol, Paris, France
[2] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, 1275 York Ave, New York, NY 10021 USA
[3] Hop Univ Strasbourg, Serv Hematol & Oncol, Strasbourg, France
[4] Univ Paris Descarte, Hop Europeen Georges Pompidou, AP HP, Oncol Dept,PARCC U790,Assoc Rech Therapeut Innova, Paris, France
[5] Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France
[6] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[7] Inst Claudius Regaud, IUCT Oncopole, Toulouse, France
[8] UPMC Univ Paris 06, Hop Trousseau A, AP HP, Serv Hematol & Oncol Pediat, Paris, France
[9] Vanderbilt Ingram Canc Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN USA
[10] Levine Canc Inst, Carolinas Healthcare Syst, Charlotte, NC USA
[11] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[12] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[13] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[14] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Oncol, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1165P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
    Boileve, A.
    Carlo, M. I.
    Barthelemy, P.
    Oudard, S.
    Borchiellini, D.
    Voss, M. H.
    George, S.
    Chevreau, C.
    Landman-Parker, J.
    Tabone, M-D
    Chism, D. D.
    Amin, A.
    Bilen, M. A.
    Bosse, D.
    Coulomb-L'hermine, A.
    Su, Xiaoping
    Choueiri, T. K.
    Tannir, Nizar M.
    Malouf, Gabriel G.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [2] Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas
    Roskoski Jr, Robert
    [J]. PHARMACOLOGICAL RESEARCH, 2024, 203
  • [3] Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
    Alhalabi, Omar
    Thouvenin, Jonathan
    Negrier, Sylvie
    Vano, Yann-Alexandre
    Campedel, Luca
    Hasanov, Elshad
    Bakouny, Ziad
    Hahn, Andrew W.
    Bilen, Mehmet Asim
    Msaouel, Pavlos
    Choueiri, Toni K.
    Viswanathan, Srinivas R.
    Sircar, Kanishka
    Albiges, Laurence
    Malouf, Gabriel G.
    Tannir, Nizar M.
    [J]. ONCOLOGIST, 2023, 28 (05): : 433 - 439
  • [4] Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma
    Mason, N.
    Kim, Y.
    Shah, S.
    Adashek, J. J.
    Manley, B. J.
    Spiess, P. E.
    Chahoud, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S692 - S692
  • [5] Clinical and pathological characteristics of renal cell carcinomas with MiTF translocation
    Filler, Tristan
    Verkarre, Virginie
    Peyrottes, Arthur
    Poinard, Florence
    Lupo, Audrey
    Dariane, Charles
    Hurel, Sophie
    Timsit, Marc -Olivier
    Mejean, Arnaud
    Audenet, Francois
    [J]. FRENCH JOURNAL OF UROLOGY, 2024, 34 (02):
  • [6] MiTF/TFE Family Renal Translocation Carcinomas Immunoexpress Cathepsin-K
    Martignoni, G.
    Pea, M.
    Gobbo, S.
    Brunelli, M.
    Bonetti, F.
    Segala, D.
    Pan, C-C
    Netto, G.
    Doglioni, C.
    Hes, O.
    Argani, P.
    Chilosi, M.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 181A - 182A
  • [7] MiTF/TFE Family Renal Translocation Carcinomas Immunoexpress Cathepsin-K
    Martignoni, G.
    Pea, M.
    Gobbo, S.
    Brunelli, M.
    Bonetti, F.
    Segala, D.
    Pan, C-C
    Netto, G.
    Doglioni, C.
    Hes, O.
    Argani, P.
    Chilosi, M.
    [J]. MODERN PATHOLOGY, 2009, 22 : 181A - 182A
  • [8] Gene expression profiling of TFE/MITF renal cell translocation carcinomas
    Philippe, Camparo
    Car, Dykema
    Kyle, Furge
    Eva, Comperat
    Yves, Denoux
    Vincent, Molinie
    Mathilde, Sibony
    Viorel, Vasiliu
    Annick, Vieillefond
    Bin, Teh
    [J]. VIRCHOWS ARCHIV, 2007, 451 (02) : 157 - 157
  • [9] Biomarkers for Targeted Therapies and Immune Checkpoint Inhibitors in Advanced NSCLC
    Zoechbauer-Mueller, Sabine
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S158 - S159
  • [10] Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
    Wirsching, Hans-Georg
    Weller, Michael
    Balabanov, Stefan
    Roth, Patrick
    [J]. CANCERS, 2021, 13 (12)